default author photo

Yoshihito Kogure

National Hospital Organization (NHO) - Department of Respiratory Medicine

Nagoya

Japan

  • National Hospital Organization (NHO) - Department of Respiratory Medicine

SCHOLARLY PAPERS

2

DOWNLOADS

173

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Radiotherapy-Free Pembrolizumab Combined with Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer with Pd-L1 TPS ≥50%: A Phase II Study (Evolution Trial: WJOG11819L)

Number of pages: 26 Posted: 23 Apr 2025
Akito Hata, Taira Ninomaru, Hideaki Okada, Yoshihito Kogure, Masahide Oki, Nobuyuki Katakami, Takashi Kijima, Toshihide Yokoyama, Hirotaka Matsumoto, Yuki Sato, Terufumi Kato, Shunichi Sugawara, Takeshi Sawada, Kenichi Yoshimura, Takashi Seto, Kazuhiko Nakagawa, Isamu Okamoto and Nobuyuki Yamamoto
Kobe Minimally Invasive Cancer Center, Kobe Minimally Invasive Cancer Center, Kobe Minimally Invasive Cancer Center, National Hospital Organization (NHO) - Department of Respiratory Medicine, National Hospital Organization (NHO) - Nagoya Medical Center, Takarazuka City Hospital, Hyogo Medical University, Kurashiki Central Hospital - Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Kobe City Medical Center General Hospital, Kanagawa Cancer Center, Sendai Kousei Hospital - Department of Pulmonary Medicine, Kyoto University, Nagoya City University, National Hospital Organization Kyushu Cancer Center, Kindai University, Kyushu University - Kyushu University Hospital and Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology
Downloads 116 (613,149)

Abstract:

Loading...

unresectable locally advanced non-small-cell lung cancer, pembrolizumab plus chemotherapy, PD-L1 high

2.

Efficacy and Safety of Carboplatin With Nab-Paclitaxel Versus Docetaxel in Elderly Patients with Squamous-Cell Lung Cancer (CAPITAL): A Randomized, Multicenter, Open-Label, Phase III Trial

Number of pages: 35 Posted: 17 May 2021
Yoshihito Kogure, Shunichiro Iwasawa, Hideo Saka, Yoichiro Hamamoto, Akiko Kada, Hiroya Hashimoto, Shinji Atagi, Yuichi Takiguchi, Noriyuki Ebi, Akira Inoue, Takayasu Kurata, Isamu Okamoto, Masafumi Yamaguchi, Toshiyuki Harada, Masahiro Seike, Takeharu Yamanaka, Masahiko Ando, Akiko M. Saito, Kaoru Kubota, Mitsuhiro Takenoyama, Takashi Seto, Nobuyuki Yamamoto and Akihiko Gemma
National Hospital Organization (NHO) - Department of Respiratory Medicine, Chiba University - Department of Respirology, National Hospital Organization (NHO) - Nagoya Medical Center, National Hospital Organization (NHO) - Nishisaitama-Chuo National Hospital, National Hospital Organization (NHO), Nagoya Medical Center, Clinical Research Center, Nagoya City University - Core Laboratory, National Hospital Organization - Department of Thoracic Oncology, Chiba University - Chiba University Hospital, Iizuka Hospital - Department of Respiratory Oncology, Tohoku University - Department of Palliative Medicine, Kansai Medical University - Kansai Medical University Hospital, Kyushu University, National Hospital Organization (NHO) - Department of Thoracic Oncology, Hokkaido University Hospital - Division of Laboratory and Transfusion Medicine, Nippon Medical School - Department of Pulmonary Medicine and Oncology, Yokohama City University - Department of Biostatistics, Nagoya University - Center for Advanced Medicine and Clinical Research, National Hospital Organization (NHO), Nagoya Medical Center, Clinical Research Center, Nippon Medical School - Department of Pulmonary Medicine and Oncology, National Hospital Organization Kyushu Cancer Center, National Hospital Organization Kyushu Cancer - Department of Thoracic Oncology,, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology and Nippon Medical School
Downloads 57 (989,921)

Abstract:

Loading...